PubRank

Hanne Mørck Nielsen

Author PubWeight™ 25.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biodegradable nanocomposite microparticles as drug delivering injectable cell scaffolds. J Control Release 2011 1.39
2 Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm 2009 0.97
3 Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method. J Control Release 2010 0.96
4 High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm 2010 0.94
5 Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure. Biochim Biophys Acta 2012 0.94
6 Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. J Control Release 2009 0.91
7 Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying. Biochim Biophys Acta 2007 0.89
8 In vitro placental model optimization for nanoparticle transport studies. Int J Nanomedicine 2012 0.88
9 alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying. Biochim Biophys Acta 2008 0.87
10 Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release 2011 0.87
11 Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo. Pharm Res 2010 0.85
12 Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo. Eur J Pharm Biopharm 2010 0.85
13 The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model-an in vitro model of the buccal epithelium. Pharm Res 2002 0.83
14 Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol 2014 0.81
15 Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process. Pharm Res 2013 0.81
16 Buccal delivery of metformin: TR146 cell culture model evaluating the use of bioadhesive chitosan discs for drug permeability enhancement. Int J Pharm 2013 0.80
17 Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation. Pharm Res 2014 0.80
18 CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations. Int J Pharm 2009 0.79
19 Oral delivery of peptides and proteins using lipid-based drug delivery systems. Expert Opin Drug Deliv 2012 0.79
20 Stabilization of liposomes during drying. Expert Opin Drug Deliv 2011 0.79
21 Design and characterization of core-shell mPEG-PLGA composite microparticles for development of cell-scaffold constructs. Eur J Pharm Biopharm 2013 0.79
22 Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli. J Med Chem 2014 0.79
23 Investigation of the interaction between modified ISCOMs and stratum corneum lipid model systems. Biochim Biophys Acta 2010 0.78
24 In vitro cutaneous application of ISCOMs on human skin enhances delivery of hydrophobic model compounds through the stratum corneum. AAPS J 2009 0.78
25 Characterization of spray dried bioadhesive metformin microparticles for oromucosal administration. Eur J Pharm Biopharm 2013 0.78
26 Solid-phase route to Fmoc-protected cationic amino acid building blocks. Amino Acids 2012 0.78
27 Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation. AAPS J 2015 0.77
28 Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01. J Control Release 2013 0.77
29 NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01. Eur J Pharm Biopharm 2008 0.77
30 Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. J Pharm Sci 2015 0.76
31 Structure of immune stimulating complex matrices and immune stimulating complexes in suspension determined by small-angle x-ray scattering. Biophys J 2012 0.76
32 Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs. Curr Pharm Des 2015 0.75
33 Evaluation of carrier-mediated siRNA delivery: lessons for the design of a stem-loop qPCR-based approach for quantification of intracellular full-length siRNA. J Control Release 2013 0.75
34 Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems. Int J Pharm 2011 0.75
35 Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery In Vitro. Methods Mol Biol 2015 0.75
36 Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems. J Pharm Sci 2013 0.75
37 Evaluation of different toxicity assays applied to proliferating cells and to stratified epithelium in relation to permeability enhancement with glycocholate. Toxicol In Vitro 2004 0.75